Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Oct 18;27(10):1610-1619.
doi: 10.1093/ibd/izaa353.

Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis

Gursimran S Kochhar  1 , Babu P Mohan  2 , Shahab R Khan  3 , Saurabh Chandan  4 , Lena L Kassab  5 , Suresh Ponnada  6 , Aakash Desai  7 , Freddy Caldera  8 , Parambir S Dulai  9 , Francis A Farraye  10
Affiliations
Meta-Analysis

Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis

Gursimran S Kochhar et al. Inflamm Bowel Dis. .

Erratum in

Abstract

Background: Data on efficacy of hepatitis-B vaccine (HBV) in patients with inflammatory bowel disease (IBD) is limited. Our aim was to review the literature and perform meta-analysis of available studies to quantify efficacy of HBV in patients with IBD.

Methods: We conducted a comprehensive search of several databases (inception to July 2020) to identify studies evaluating efficacy of HBV in patients with IBD. Random effects model was used to calculate the pooled rates and I2 percentage values were used to assess the heterogeneity.

Results: A total of 14 studies (2375 patients) were included. Four data sets were available from 2 studies that compared HBV response in patients with IBD against healthy controls. The pooled odds ratio of HBV response in IBD patients was 0.13 (95% CI, 0.05-0.33, P = 0.001). The pooled proportion of adequate immune response (AIR) was 64% (95% CI, 55-72.1, P = 0.003) from 13 data sets, and effective immune response (EIR) was 39.7% (95% CI, 30.7-49.5, P = 0.04) from 10 data sets.

Conclusion: Patients with IBD on immunosuppression demonstrated significantly reduced HBV response as compared with general population.

Keywords: hepatitis-B vaccination response; inflammatory bowel disease; meta-analysis.

PubMed Disclaimer

Substances